Strategic Consensus on the Value of Immuno-Oncology in Portugal
The Institute of Health Sciences of Universidade Católica Portuguesa held on September 27th a public session to present the results of ADVANCE IO - Strategic Consensus on the Value of Immuno-Oncology in Portugal. The study, an initiative of the Institute of Public Health of the Universidade Católica...
Saved in:
Main Author: | . . (Author) |
---|---|
Format: | Book |
Published: |
Formifarma, LDA.,
2016-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concepts for agonistic targeting of CD40 in immuno-oncology
by: David M. Richards, et al.
Published: (2020) -
Novel strategies for immuno-oncology breakthroughs with cell therapy
by: Hongtao Liu, et al.
Published: (2021) -
Immuno-Oncology Medicines: Policy Implications and Economic Considerations
by: Georges Adunlin, et al.
Published: (2019) -
Immune landscape and biomarkers for immuno-oncology in colorectal cancers
by: Jeong Mo Bae, et al.
Published: (2020) -
The hubris and humility of cancer pharmacology in the post immuno‐oncology era
by: John S. Lazo
Published: (2019)